Top Markets
Coin of the day
Novogene Co., Ltd. Novogene Co., Ltd.

Novogene Co., Ltd.

688315
Hisse Senetlerindeki Sıralama #9857
Novogene Co., Ltd. is a global provider of comprehensive genomic services and... Novogene Co., Ltd. is a global provider of comprehensive genomic services and advanced solutions. Its offerings span a wide array of genomic applications, including human, animal, plant, and microbial genome sequencing, alongside gene regulation and single-cell sequencing technologies. The company also specializes in cancer genomic profiling, whole exome sequencing (including clinical-grade versions), and FFPE RNA sequencing. Furthermore, Novogene develops proprietary tools such as NovoFocus, a next-generation sequencing (NGS)-based companion diagnostic for PARP inhibitor treatments, and NovoNeoantigen, a bioinformatics pipeline that identifies cancer neoantigens by analyzing whole exome and whole transcriptome sequencing data from matched tumor and normal samples. In a strategic collaboration, Novogene partners with Hummingbird Bioscience Pte. Ltd. to aid in the advancement of HMBD-001. This investigational anti-HER3 antibody is being assessed for its potential to treat diverse cancer types, notably those driven by NRG1-fusion. Established in 2011, Novogene Co., Ltd. operates from its headquarters in Beijing, China.
Hisse Fiyatı
$2.25
Son senkronizasyon: 2026-08-28
Piyasa Değeri
$936.66M
Değişim (1 gün)
-3.18%
Değişim (1 yıl)
3.07%
Ülke
CN
Ticaret Novogene Co., Ltd. (688315)

Kategori

Novogene Co., Ltd. (688315) için temettü verimi geçmişi
Novogene Co., Ltd. (hisse sembolü: 688315) temettü verimi (TTM) 2026 itibariyle: 0
Son 5 yılın ortalama temettü verimi: 0.00%
Novogene Co., Ltd. (688315) için 2026 - 2026 arası temettü verimi geçmişi
Her yılın sonunda temettü verimi (TTM)
Yıl Temettü Verimi Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakiplerin temettü verimi (TTM)
Şirket Temettü Verimi Ülke
0.00%
US
0.00%
NL
3.12%
AU
0.00%
US
0.00%
CH